E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 8/31/2006 in the Prospect News Biotech Daily.

Calypte listed as CBMC on the Pink Sheets

By Lisa Kerner

Charlotte, N.C., Aug. 31 - Calypte Biomedical Corp. said its new common stock symbol CBMC is now being quoted on the Pink Sheets.

Calypte, current in all Securities and Exchange Commission filings, voluntarily withdrew its common stock from the American Stock Exchange earlier this year.

The company is a Lake Oswego, Ore., medical diagnostic test manufacturer.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.